Denali Therapeutics shares owned by Crestline Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Crestline Management
from 13F filings
Historical chart of Crestline Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Crestline Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Crestline Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $122M | 5.7M | 21.46 |
| 2023-09-30 | $123M | 6.0M | 20.63 |
| 2023-06-30 | $180M | 6.1M | 29.51 |
| 2023-03-31 | $148M | 6.4M | 23.04 |
| 2022-12-31 | $191M | 6.9M | 27.81 |
| 2022-09-30 | $220M | 7.2M | 30.69 |
| 2022-06-30 | $220M | 7.5M | 29.43 |
| 2022-03-31 | $240M | 7.5M | 32.17 |
| 2021-12-31 | $344M | 7.7M | 44.60 |
| 2021-09-30 | $389M | 7.7M | 50.45 |
| 2021-06-30 | $638M | 8.1M | 78.44 |
| 2021-03-31 | $570M | 10M | 57.10 |
| 2020-12-31 | $339M | 20M | 17.42 |
| 2020-09-30 | $437M | 12M | 35.83 |
| 2020-06-30 | $330M | 14M | 24.18 |
| 2020-03-31 | $273M | 16M | 17.51 |
| 2019-12-31 | $339M | 20M | 17.42 |
| 2019-09-30 | $298M | 20M | 15.32 |
| 2019-06-30 | $404M | 20M | 20.76 |
| 2019-03-31 | $452M | 20M | 23.22 |
| 2018-12-31 | $402M | 20M | 20.66 |
| 2018-09-30 | $447M | 21M | 21.74 |
| 2018-06-30 | $314M | 21M | 15.25 |
| 2018-03-31 | $405M | 21M | 19.69 |
| 2017-12-31 | $322M | 21M | 15.64 |